HDAC2 and cancer: In contrast to our present results, mounting evidence indicates that HDAC2 is aberrantly overexpressed in a variety of cancer tissues and implicated in the promotion of malignant phenotypes of certain cancer cells such as anti‐cancer drug resistance.